StudyFinder
Search Results
1 Study Matches
CCTG MA.39- A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Purpose of this study is to compare any good and bad effects of not using regional radiotherapy to using radiotherapy. The study will help researcher learn if not giving regional radiotherapy is just as good as using regional therapy to treat node positive breast cancer in women.
Blood will be drawn at two time points and number of visits will be determined by the individual radiation treatment plan.
Michelle Eschbach - at meschbach@pennstatehealth.psu.edu or 610-378-2336
Female
18 year(s) or older
NCT03488693
AFFILCCTGMA39
Inclusion Criteria:
Estrogen Receptor Positive / Her2 Negative Breast CancerNo evidence of metastasis
1 - 3 positive lymph nodes
May have had breast conserving surgery or mastectomy
35 years of age or older
Exclusion Criteria:
Nodal disease limited to micromets or isolated cellsHistory of ipsilateral breast cancer or DCIS
Synchronous or contralateral breast cancer
pT4 disease
Neoadjuvant Chemotherapy for breast cancer
Cancer